1. 3 potential blockbusters under FDA review — AbbVie gets the most out of its workers — Roche/Exelixis’ Cotellic fizzles in melanoma study — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Nuedexta

Discussion in 'Otsuka' started by Anonymous, Jan 24, 2015 at 10:52 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Does anyone know anything about this drug? Is the formulary coverage generally good?
     

  2. Anonymous

    Anonymous Guest

    Is it a good product?
     
  3. Anonymous

    Anonymous Guest

    Coverage is good, they also have co pay cards an samples.
    But disease state is small unless you can get doctors to try it in other areas.
    More and better indications are on the way (the real reason Otsuka bought Avanir.)
    They are also launching a new Migraine drug in Nov.
     
  4. Anonymous

    Anonymous Guest

    A blockbuster like Lipitor
     
  5. Anonymous

    Anonymous Guest

    Another CIA in the makin'. Document everything. Someday you will be glad you did.
     
  6. Anonymous

    Anonymous Guest

     
  7. Anonymous

    Anonymous Guest

    Few have this disease. It's not common at all.
     
  8. Anonymous

    Anonymous Guest

    My doctors say they do not see or treat PBA. Can someone explain to me why we are taking time away from our multi billion dollar product to learn this? If they are keeping Avanirs reps this is utterly retarded!!!!!
     
  9. Anonymous

    Anonymous Guest

    gee maybe because the patent is expiring
     
  10. Anonymous

    Anonymous Guest

    I agree. PBA is so rare. It's a joke for most. It's definitely going to be a hard sell.
     
  11. Anonymous

    Anonymous Guest

    The Avanir reps were told on Friday that they will No longer call on
    Psychs after July 1st,2015.
    Only Otsuka reps will.
    Avanir reps will only call on Neuros.
     
  12. Anonymous

    Anonymous Guest

    Does that include the LTC Avanir Account Managers?
     
  13. Anonymous

    Anonymous Guest

    I have a feeling Avanir and Samsca Hospital will merge.
    Blue Team better get used to the fact that we will not receive sales credit for nursing homes.
     
  14. Anonymous

    Anonymous Guest

    No, only their retail sales force. (will not call on psychs after July 1st)
    Their LTC sales force will continue to call on nursing homes an doctors
    that go to nursing homes. If a psych goes to nursing homes a Avanir LTC
    rep will call on him.
     
  15. Anonymous&

    Anonymous& Guest

    This product any good?
     
  16. Anonymous

    Anonymous Guest

    Its a good product, it works great for PBA, but problem is doctors say they don't see PBA,
    especially the psychs. Hopefully we get the agitation indication soon.
     
  17. anonymous

    anonymous Guest

    There are a number of published reports indicating that Neudexta offers major benefits (including control of anxiety and other emotional problems) in Alzheimer patients. A quick search that combines Neudexta with Alzheimer will take you to numerous links. And THAT appears to be BIG news. Far bigger than anything related to "pseudo-bulbar affect", a badly-chosen phrase for a neurological problem that is more widespread than most people realize (since it usually drives sufferers into becoming recluses and hermits who don't want anyone except close family and friends to know anything about their peculiar problem).
     
  18. anonymous

    anonymous Guest

    this drug is tough to sell to my psychs
     
  19. anonymous

    anonymous Guest

    So do you all call on cmhc? I would think this would be a hard sell for psych...
     
  20. anonymous

    anonymous Guest

    whatever happened to the Avanir people?